Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$772,923
New position
Shares Held
28,648
first reported quarter
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#125
of 224 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jupiter Topco LLC holds $19,715,839,486 across 191 Biotechnology names. MLYS ranks #143 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,474,015 | $2,295,316,893 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
10,736,145 | $2,010,665,232 | |
| 3 | PRAX |
Praxis Precision Medicines, Inc.
|
3,421,374 | $1,145,441,799 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
14,110,278 | $1,050,933,503 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
17,965,847 | $1,044,354,683 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,936,099 | $1,039,588,355 | |
| 7 | ASND |
Ascendis Pharma A/S
|
3,648,772 | $973,200,466 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
5,909,184 | $691,788,169 |
All Filings in MLYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $772,923 | 28,648 | Shares | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||